Welcome to our dedicated page for Aveanna Healthcare Holdings news (Ticker: AVAH), a resource for investors and traders seeking the latest updates and insights on Aveanna Healthcare Holdings stock.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is described as a diversified home care platform focused on medically complex, high-cost patient populations, with headquarters in Atlanta, Georgia and locations in 38 states. The AVAH news page on Stock Titan aggregates company press releases and market updates that explain how Aveanna delivers pediatric and adult nursing, therapy, home health, hospice, and medical product services in home and community settings.
Visitors to this page can review Aveanna’s own announcements on topics such as updated full year financial guidance, preliminary and final quarterly results, and commentary on non-GAAP measures like EBITDA, Adjusted EBITDA, and Normalized Adjusted EBITDA. News items also cover participation in healthcare and finance conferences, including events hosted by financial institutions, where the company’s management presents to investors and holds one-on-one meetings.
Other Aveanna releases describe capital markets activity and financing developments, such as secondary offerings of common stock by existing stockholders and amendments to credit facilities and term loans. These updates provide context on the company’s capital structure, refinancing transactions, and relationships with lenders and underwriters.
Because Aveanna positions its services as a high quality, lower cost alternative to prolonged hospitalization, news about its financial performance, strategic financing actions, and investor presentations can be relevant to those tracking trends in home-based care for medically fragile and chronically ill children and adults. For ongoing coverage of AVAH, investors and observers can use this page to follow the company’s reported milestones, regulatory disclosures referenced in press releases, and other public communications.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced an agreement to acquire Thrive Skilled Pediatric Care, one of the largest independent pediatric home care providers. The acquisition, expected to close in Q2 2025, will expand Aveanna's presence across seven states, including two new markets.
Thrive SPC operates 23 locations across Arizona, Georgia, Kansas, New Mexico, North Carolina, Virginia, and Texas, primarily offering Private Duty Nursing services along with Pediatric Therapy, Licensed Health Aide Services, and Certified Nurse Assistant Services.
The transaction will be funded through a combination of common stock shares and cash from Aveanna's balance sheet. Edge Healthcare Partners and Bass, Berry & Sims served as Aveanna's advisors, while Cantor Fitzgerald & Co. and Ropes & Gray LLP represented Thrive SPC.
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported strong Q4 2024 financial results, with revenue increasing 8.6% to $519.9 million compared to Q4 2023. The company achieved significant improvements with a net income of $29.2 million, contrasting with a $25.7 million loss in the prior year period.
Key Q4 metrics include a 15.7% increase in gross margin to $171.7 million and a 42.8% rise in Adjusted EBITDA to $55.2 million. For the full year 2024, revenue reached $2.02 billion, up 6.8% from 2023, while Adjusted EBITDA grew 31.9% to $183.6 million.
Looking ahead, Aveanna provided 2025 guidance projecting revenue between $2.10-2.12 billion and Adjusted EBITDA between $190-194 million. The company maintains a strong liquidity position with $84.3 million in cash and additional borrowing capacity through various facilities.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has scheduled its fourth quarter and full year 2024 earnings release for Thursday, March 13, 2025, before market open. The company will host a conference call at 10:00 a.m. Eastern Time on the same day.
Investors can access the conference call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (International). A replay will be available for one week until March 20, 2025, accessible via 1-844-512-2921 (US) or 1-412-317-6671 (International) using passcode 13750192. Additionally, a simultaneous webcast will be available on the company's Investor Relations website at ir.aveanna.com.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management team will deliver a presentation on January 15, 2025 at 10:30 a.m. PST, followed by one-on-one investor meetings throughout the day.
Investors and interested parties can access a live webcast of the presentation through Aveanna's Investor Relations website at ir.aveanna.com. A replay of the presentation will be available for a time after the event.
Aveanna Healthcare Holdings reported strong Q3 2024 financial results with revenue of $509.0 million, up 6.5% year-over-year. Gross margin increased 8.4% to $159.7 million, while net loss improved to $42.8 million from $102.4 million in Q3 2023. Adjusted EBITDA grew 32.2% to $47.8 million. The company raised its full-year 2024 guidance, projecting revenue of approximately $2.0 billion and Adjusted EBITDA greater than $168 million. The improved performance was attributed to better payor rates and successful cost reduction efforts.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has appointed Brent Layton as a Class III director and Audit Committee member, effective November 1, 2024. Layton, currently CEO of Sharecare, brings over 20 years of healthcare leadership experience from Centene , where he served as president and COO. In his previous role, he oversaw 31 state Medicaid health plans, Ambetter, and WellCare. The appointment aims to leverage Layton's extensive experience in healthcare policy and managed care organizations to support Aveanna's strategic growth initiatives.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced its participation in the Stephens Annual Investment Conference. The company's management team will be attending virtually on Friday, November 22, 2024. During the conference, Aveanna's executives will be hosting one-on-one meetings with investors.
This virtual attendance at the investment conference provides an opportunity for Aveanna to engage with potential investors and discuss the company's performance, strategies, and future prospects. The one-on-one format allows for more focused and personalized interactions between the company's management and interested investors.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced its schedule for releasing third quarter 2024 financial results. The company will disclose its Q3 results before the market opens on Thursday, November 7, 2024. This will be followed by a conference call at 10:00 a.m. Eastern Time on the same day.
Investors can access the conference call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (international). A replay will be available three hours after the call until November 14, 2024, accessible via 1-844-512-2921 (US) or 1-412-317-6671 (international). The passcode for both the live call and replay is 13748484.
Additionally, a simultaneous webcast of the conference call will be available on the Investor Relations section of Aveanna's website at https://ir.aveanna.com/. The online replay will remain accessible for one week following the call.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced its participation in the Deutsche Bank Annual Leveraged Finance Conference on September 24, 2024, in Scottsdale, AZ. The company's management team will be hosting one-on-one investor meetings during the event.
Aveanna Healthcare, headquartered in Atlanta, Georgia, operates in 33 states across the US. The company offers a wide range of healthcare services for both pediatric and adult patients, including:
- Nursing and rehabilitation services
- Occupational nursing in schools
- Therapy services
- Day treatment centers for medically fragile patients
- Home health and hospice services
- Enteral nutrition delivery
- Case management services
- Respite healthcare services
Aveanna's services aim to provide high-quality, cost-effective alternatives to prolonged hospitalization.
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported strong Q2 2024 results, with revenue increasing 7.0% to $505.0 million and Adjusted EBITDA growing 27.3% to $45.6 million compared to Q2 2023. The company's gross margin increased 1.9% to $158.3 million. Net income was $13.9 million, down from $25.6 million in the prior year period. Based on these positive results, Aveanna has raised its full-year 2024 guidance, projecting revenue greater than $1,985 million and Adjusted EBITDA exceeding $158 million. The company attributes its success to ongoing strategic transformation efforts and enhanced payor partnerships, allowing for expanded care delivery and investment in caregivers.